Although GIP is the primary incretin hormone in healthy individuals and plays a crucial role in incretin effects, its insulin response is significantly reduced in individuals with T2DM who have uncontrolled hyperglycemia, a phenomenon referred to as GIP resistance [6]. This evidence concerns the gene GIP and type 2 diabetes mellitus.